277 related articles for article (PubMed ID: 24532037)
1. Repurposing of gallium-based drugs for antibacterial therapy.
Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
[TBL] [Abstract][Full Text] [Related]
2. Promises and failures of gallium as an antibacterial agent.
Minandri F; Bonchi C; Frangipani E; Imperi F; Visca P
Future Microbiol; 2014; 9(3):379-97. PubMed ID: 24762310
[TBL] [Abstract][Full Text] [Related]
3. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
4. Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms.
Chromy BA; Elsheikh M; Christensen TL; Livingston D; Petersen K; Bearinger JP; Hoeprich PD
Future Microbiol; 2012 Aug; 7(8):1011-20. PubMed ID: 22913359
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions.
Cox G; Wright GD
Int J Med Microbiol; 2013 Aug; 303(6-7):287-92. PubMed ID: 23499305
[TBL] [Abstract][Full Text] [Related]
8. Nature's clarion call of antibacterial resistance: are we listening?
Theuretzbacher U; Toney JH
Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
[TBL] [Abstract][Full Text] [Related]
9. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.
Baquero F; Coque TM; Cantón R
Expert Opin Ther Targets; 2014 Aug; 18(8):851-61. PubMed ID: 24881465
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomics unveils the bacteriostatic mechanisms of Ga(III) on the regulation of metabolic pathways in Pseudomonas aeruginosa.
Wang Y; Yang X; Zhang S; Ai J; Wang J; Chen J; Zhao L; Wang W; You H
J Proteomics; 2023 Oct; 289():105011. PubMed ID: 37776994
[TBL] [Abstract][Full Text] [Related]
11. What's new on the antimicrobial horizon?
Song JH
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of antibiotics to combat antimicrobial resistance.
Dubey KK; Indu ; Sharma M
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
[TBL] [Abstract][Full Text] [Related]
13. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
14. Alternative natural sources for a new generation of antibacterial agents.
Taylor PW
Int J Antimicrob Agents; 2013 Sep; 42(3):195-201. PubMed ID: 23796893
[TBL] [Abstract][Full Text] [Related]
15. Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance.
Huque MF; Valappil T; Soon GG
Stat Med; 2014 Nov; 33(25):4321-36. PubMed ID: 24957660
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections.
Vinuesa V; McConnell MJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809032
[TBL] [Abstract][Full Text] [Related]
17. Combination drugs, an emerging option for antibacterial therapy.
Cottarel G; Wierzbowski J
Trends Biotechnol; 2007 Dec; 25(12):547-55. PubMed ID: 17997179
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors.
Yssel AEJ; Vanderleyden J; Steenackers HP
J Antimicrob Chemother; 2017 Aug; 72(8):2156-2170. PubMed ID: 28575223
[TBL] [Abstract][Full Text] [Related]
19. [Research progress of new antibacterial drugs that target bacterial quorum sensing systems].
Yin SL; Chang YJ; Deng SP; Wang QC; Yu WG; Gong QH
Yao Xue Xue Bao; 2011 Jun; 46(6):613-21. PubMed ID: 21882519
[TBL] [Abstract][Full Text] [Related]
20. Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii.
Chopra S; Torres-Ortiz M; Hokama L; Madrid P; Tanga M; Mortelmans K; Kodukula K; Galande AK
J Antimicrob Chemother; 2010 Dec; 65(12):2598-601. PubMed ID: 20861141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
